Cranial Immobilization System Receives CE Mark

January 31, 2011 – A patient-specific cranial immobilization system has received the CE mark. The Fraxion head frame, by Elekta, helps ensure accuracy and precision in stereotactic radiation therapy of cancer targets in the brain and cranium. The Fraxion is the first to integrate all proven cranial immobilization options in a single system. "The advantage of Fraxion head fixation is that it is a stereotactic system that can be used for nearly any patient," says Meinhard Nevinny-Stickel, M.D., a radiation oncologist in the department of therapeutic radiology and oncology, Medical University Innsbruck in Austria. "The patient can be immobilized with a thermoplastic mask, with the proven vacuum mouthpiece, or even a combination of both systems. Precise repositioning is possible with easily accessible adjustment screws – which make it much easier to fixate the patient in the treatment room." The partial and full head thermoplastic masks provide alternative immobilization options for non-invasive setup, without compromising accuracy. Combining the thermoplastic mask with the vacuum mouthpiece increases flexibility in setup options, allowing optimal setup based on the patient's needs. It also features a target positioner, which provides accurate target localization for stereotactic planning, imaging and treatment. For more information: www.elekta.com

 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now